Total Funding
72
50
Total FundingGrant raised
Growth Score 72 in past quarter
-18 pts
Heat Score 50 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
117132
Proteomics International is a pioneering medical technology company.
- Vik Malik: Chief Commercialisation Officer
- Richard Lipscombe: Managing Director & co-founder
About the Company
Proteomics International is a pioneering medical technology company operating at the forefront of predictive diagnostics and bio-analytical services. The Company specialises in the area of proteomics – the industrial scale study of the structure and function of proteins.
Proteomics International’s aim is to use its expertise in proteins to develop
and commercialise diagnostic tests for chronic diseases where there is unmet medical need.
